NachrichtenKI-unterstützt

SIGA Technologies Strengthens Leadership with General Jack Keane’s Appointment

SIGA welcomes General Jack Keane to its board, reinforcing its commitment to national security and biodefense.

Mrudula Kulkarni
Von Mrudula Kulkarni
Redaktionsleiter – Pharma Now
19. März 2025Updated Jun 26, 2025 · 2 Min. Lesezeit
SIGA Technologies Strengthens Leadership with General Jack Keane’s Appointment
freepik.com
KI-unterstützte Berichterstattung
Reviewed by Mrudula Kulkarni, Redaktionsleiter – Pharma Now

SIGA Technologies, Inc. has appointed retired four-star General John "Jack" Keane to its Board of Directors, bringing decades of leadership and national security expertise to the company. With a distinguished military career spanning 37 years, including serving as acting Chief of Staff and Vice Chief of Staff of the U.S. Army, General Keane has played a pivotal role in shaping U.S. defense strategies. Beyond his military service, he has advised global leaders, testified before Congress, and contributed expert analysis on foreign policy. His appointment strengthens SIGA’s mission to expand its antiviral TPOXX and enhance national biodefense preparedness.

Diem Nguyen, CEO of SIGA Technologies, praised General Keane’s addition, emphasizing his unparalleled insights into global security challenges. General Keane expressed enthusiasm for the role, citing his lifelong commitment to strategic readiness and national defense. As SIGA continues its work supplying antiviral solutions to the U.S. and international partners, his guidance is expected to play a key role in advancing the company’s strategic initiatives.

Mrudula Kulkarni
Written by
Mrudula Kulkarni
Redaktionsleiter – Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Diskussion wird geladen…

Mehr aus Pharma News

Alle Beiträge →